Eli Lilly and Co
NYSE:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eli Lilly and Co
NYSE:LLY
|
US |
|
Lojas Renner SA
BOVESPA:LREN3
|
BR |
|
Kimberly-Clark Corp
NASDAQ:KMB
|
US |
|
Sinch AB (publ)
OTC:CLCMF
|
SE |
|
U
|
Ultimovacs ASA
OSE:ULTI
|
NO |
|
CK Hutchison Holdings Ltd
HKEX:1
|
HK |
Wall St Price Targets
LLY Price Targets Summary
Eli Lilly and Co
According to Wall Street analysts, the average 1-year price target for LLY is 1 231.74 USD with a low forecast of 858.5 USD and a high forecast of 1 575 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LLY's stock price target?
Price Target
1 231.74
USD
According to Wall Street analysts, the average 1-year price target for LLY is 1 231.74 USD with a low forecast of 858.5 USD and a high forecast of 1 575 USD.
What is the Revenue forecast for Eli Lilly and Co?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 20%.
What is the Gross Profit forecast for Eli Lilly and Co?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 19%.
What is the Operating Income forecast for Eli Lilly and Co?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 3 years is 24%.
What is the Pre-Tax Income forecast for Eli Lilly and Co?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 31%.
What is the Net Income forecast for Eli Lilly and Co?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 3 years is 31%.
